Cosmecca Korea Co., Ltd. (KOSDAQ:241710)
78,200
+3,000 (3.99%)
At close: Apr 9, 2026
Cosmecca Korea Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 640,929 | 524,329 | 470,719 | 399,399 | 396,466 |
Other Revenue | - | -0 | -0 | -0 | - |
| 640,929 | 524,329 | 470,719 | 399,399 | 396,466 | |
Revenue Growth (YoY) | 22.24% | 11.39% | 17.86% | 0.74% | 16.93% |
Cost of Revenue | 483,513 | 400,197 | 364,168 | 334,958 | 324,578 |
Gross Profit | 157,416 | 124,132 | 106,551 | 64,441 | 71,888 |
Selling, General & Admin | 53,208 | 40,093 | 36,341 | 33,736 | 31,430 |
Research & Development | 16,871 | 13,813 | 13,338 | 13,628 | 11,793 |
Amortization of Goodwill & Intangibles | 567.5 | 3,081 | 2,987 | 2,917 | 2,848 |
Other Operating Expenses | 1,411 | 1,072 | 1,034 | 807.14 | 1,049 |
Operating Expenses | 73,880 | 63,769 | 57,397 | 54,074 | 51,833 |
Operating Income | 83,537 | 60,362 | 49,154 | 10,367 | 20,055 |
Interest Expense | -3,543 | -3,197 | -4,021 | -3,672 | -2,964 |
Interest & Investment Income | 1,020 | 873.42 | 313.33 | 121.13 | 34.97 |
Earnings From Equity Investments | -208.43 | -147.09 | 264.96 | -81.21 | -56.99 |
Currency Exchange Gain (Loss) | -313.21 | 9,242 | -24.62 | -92.26 | 2,859 |
Other Non Operating Income (Expenses) | -918.07 | 684.66 | -19.93 | 500.34 | 749.26 |
EBT Excluding Unusual Items | 79,575 | 67,818 | 45,667 | 7,143 | 20,677 |
Gain (Loss) on Sale of Investments | 22.39 | 34.5 | 107.79 | 61.86 | 632.03 |
Gain (Loss) on Sale of Assets | -12.92 | 8.68 | 327.31 | -608.14 | -1,671 |
Asset Writedown | -1,696 | -266.87 | - | -224.1 | -367.97 |
Other Unusual Items | - | - | - | - | -1,755 |
Pretax Income | 77,888 | 67,594 | 46,102 | 6,373 | 17,514 |
Income Tax Expense | 20,049 | 13,906 | 12,215 | 370.12 | 546.83 |
Earnings From Continuing Operations | 57,838 | 53,688 | 33,887 | 6,003 | 16,967 |
Minority Interest in Earnings | -12,399 | -10,888 | -11,568 | -3,347 | -8,063 |
Net Income | 45,440 | 42,800 | 22,319 | 2,656 | 8,904 |
Net Income to Common | 45,440 | 42,800 | 22,319 | 2,656 | 8,904 |
Net Income Growth | 6.17% | 91.76% | 740.32% | -70.17% | 239.62% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 |
EPS (Basic) | 4254.67 | 4007.50 | 2089.82 | 248.69 | 833.71 |
EPS (Diluted) | 4254.67 | 4007.50 | 2089.82 | 248.69 | 833.71 |
EPS Growth | 6.17% | 91.76% | 740.32% | -70.17% | 239.62% |
Free Cash Flow | -6,342 | 20,803 | 23,400 | 5,115 | -1,091 |
Free Cash Flow Per Share | -593.81 | 1947.85 | 2191.02 | 478.95 | -102.17 |
Dividend Per Share | 370.000 | - | - | - | - |
Gross Margin | 24.56% | 23.67% | 22.64% | 16.13% | 18.13% |
Operating Margin | 13.03% | 11.51% | 10.44% | 2.60% | 5.06% |
Profit Margin | 7.09% | 8.16% | 4.74% | 0.66% | 2.25% |
Free Cash Flow Margin | -0.99% | 3.97% | 4.97% | 1.28% | -0.27% |
EBITDA | 100,049 | 78,161 | 65,926 | 27,091 | 36,463 |
EBITDA Margin | 15.61% | 14.91% | 14.01% | 6.78% | 9.20% |
D&A For EBITDA | 16,512 | 17,798 | 16,772 | 16,724 | 16,408 |
EBIT | 83,537 | 60,362 | 49,154 | 10,367 | 20,055 |
EBIT Margin | 13.03% | 11.51% | 10.44% | 2.60% | 5.06% |
Effective Tax Rate | 25.74% | 20.57% | 26.50% | 5.81% | 3.12% |
Advertising Expenses | 708.83 | 566.4 | 360.86 | 162.32 | 236.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.